Literature DB >> 6402322

Some considerations of methodology and standardization of apolipoprotein A-I immunoassays.

K K Steinberg, G R Cooper, S R Graiser, M Rosseneu.   

Abstract

Apolipoprotein A-I (apo A-I) is the major protein of high-density lipoprotein. Compelling evidence suggests that measurement of concentrations of apo A-I in serum may be useful in predicting and assessing ischemic heart disease. The following review of methods of isolation, characterization, and assay of apo A-I has been developed to assess the possibility of standardizing apo A-I immunoassays. We consider the properties of apo A-I that have an effect on its quantification, such as self-association, polymorphism, and stability characteristics. We attempt to review critically the various methods presented, but more information about the physicochemical properties of the protein is required before definitive recommendations can be made.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402322

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  The concentration of apolipoprotein A-I decreases during experimentally induced acute-phase processes in pigs.

Authors:  R Carpintero; M Piñeiro; M Andrés; M Iturralde; M A Alava; P M H Heegaard; J L Jobert; F Madec; F Lampreave
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

3.  Plasma and lipoprotein lipids and apolipoproteins AI, AII and B in patients with chronic airflow limitation.

Authors:  C H Bolton; E Mulloy; J Harvey; L G Downs; M Hartog
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.